Singular Genomics Systems, Inc. (OMIC) has entered into an agreement to be acquired by Deerfield for $20 per share in cash. This acquisition follows a previous offer of $24 per share made in November. The stock of OMIC was halted prior to this announcement. In a related development, Ikena Oncology (IKNA) and Inmagene Biopharmaceuticals have announced a merger agreement that includes a $175 million investment to support the development of IMG-007, which will also involve a $75 million private placement. The combined entity will operate under the name ImageneBio and is expected to close by mid-2025, with plans to trade on Nasdaq under the ticker 'IMA'. Additionally, NeueHealth (NEUE) is set to be taken private by NEA and a consortium of investors, leading to a pre-market increase of 63.8% in its stock price. Halper Sadeh LLC is investigating whether the sale of both Singular Genomics and NeueHealth is fair to their respective shareholders.